S&P 500   2,998.05 (+1.08%)
DOW   27,046.39 (+0.97%)
QQQ   193.61 (+1.32%)
AAPL   235.87 (+0.00%)
FB   189.12 (+3.19%)
MSFT   141.53 (+1.42%)
AMZN   1,768.17 (+1.83%)
NVDA   196.93 (+5.58%)
MU   46.50 (+3.66%)
BABA   175.22 (+2.37%)
GE   8.88 (+1.72%)
AMD   30.79 (+0.85%)
T   37.93 (+1.20%)
F   9.08 (+2.83%)
ACB   3.78 (+7.70%)
NFLX   284.22 (-0.46%)
BAC   29.90 (+2.61%)
DIS   130.10 (+0.31%)
S&P 500   2,998.05 (+1.08%)
DOW   27,046.39 (+0.97%)
QQQ   193.61 (+1.32%)
AAPL   235.87 (+0.00%)
FB   189.12 (+3.19%)
MSFT   141.53 (+1.42%)
AMZN   1,768.17 (+1.83%)
NVDA   196.93 (+5.58%)
MU   46.50 (+3.66%)
BABA   175.22 (+2.37%)
GE   8.88 (+1.72%)
AMD   30.79 (+0.85%)
T   37.93 (+1.20%)
F   9.08 (+2.83%)
ACB   3.78 (+7.70%)
NFLX   284.22 (-0.46%)
BAC   29.90 (+2.61%)
DIS   130.10 (+0.31%)
Log in

Syros Pharmaceuticals News Headlines (NASDAQ:SYRS)

$9.40
+0.69 (+7.92 %)
(As of 10/15/2019 03:37 PM ET)
Today's Range
$8.70
Now: $9.40
$9.70
50-Day Range
$8.16
MA: $10.16
$11.65
52-Week Range
$5.17
Now: $9.40
$11.93
Volume143,475 shs
Average Volume128,208 shs
Market Capitalization$398.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.61

Headlines

Syros Pharmaceuticals (NASDAQ SYRS) News Headlines

Source:
DateHeadline
Syros Pharmaceuticals Inc (NASDAQ:SYRS) Receives Consensus Rating of "Buy" from AnalystsSyros Pharmaceuticals Inc (NASDAQ:SYRS) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - September 25 at 2:40 PM
Syros Pharmaceuticals Inc (NASDAQ:SYRS) Expected to Announce Earnings of -$0.51 Per ShareSyros Pharmaceuticals Inc (NASDAQ:SYRS) Expected to Announce Earnings of -$0.51 Per Share
www.americanbankingnews.com - September 23 at 10:31 PM
Does Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Have A Volatile Share Price?Does Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Have A Volatile Share Price?
finance.yahoo.com - September 21 at 3:10 PM
Syros Pharmaceuticals moving HQ out of East CambridgeSyros Pharmaceuticals moving HQ out of East Cambridge
finance.yahoo.com - September 13 at 1:57 PM
Syros to Present at 2019 Wedbush PacGrow Healthcare ConferenceSyros to Present at 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 4:30 PM
Syros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q2 2019 Results - Earnings Call TranscriptSyros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 11:23 AM
Edited Transcript of SYRS earnings conference call or presentation 1-Aug-19 12:30pm GMTEdited Transcript of SYRS earnings conference call or presentation 1-Aug-19 12:30pm GMT
finance.yahoo.com - August 3 at 3:48 PM
Syros Pharmaceuticals, Inc.(SYRS) Q2 2019 Earnings Call TranscriptSyros Pharmaceuticals, Inc.(SYRS) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 3 at 10:23 AM
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue EstimatesSyros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 1 at 1:14 PM
Syros to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019Syros to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019
finance.yahoo.com - July 25 at 1:01 PM
Does Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Pay Compare Well With Peers?Does Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Pay Compare Well With Peers?
finance.yahoo.com - June 27 at 3:57 PM
What Did Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Take Home Last Year?What Did Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Take Home Last Year?
finance.yahoo.com - June 27 at 3:57 PM
Syros to Present at JMP Securities Life Sciences ConferenceSyros to Present at JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 9:10 AM
Syros Announces Appointment of Alice T. Shaw to its Board of DirectorsSyros Announces Appointment of Alice T. Shaw to its Board of Directors
finance.yahoo.com - June 13 at 9:10 AM
Checking In On Syros PharmaceuticalsChecking In On Syros Pharmaceuticals
seekingalpha.com - May 24 at 3:41 PM
New Publication in Cancer Research Highlights Discovery of SY-1365, a First-in-Class Selective CDK7 Inhibitor, and its Promise as a Potentially Transformative Targeted Approach for Difficult-to-Treat CancersNew Publication in Cancer Research Highlights Discovery of SY-1365, a First-in-Class Selective CDK7 Inhibitor, and its Promise as a Potentially Transformative Targeted Approach for Difficult-to-Treat Cancers
finance.yahoo.com - May 7 at 11:55 AM
Edited Transcript of SYRS earnings conference call or presentation 1-May-19 12:30pm GMTEdited Transcript of SYRS earnings conference call or presentation 1-May-19 12:30pm GMT
finance.yahoo.com - May 3 at 11:56 AM
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q1 2019 Results - Earnings Call TranscriptSyros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 2 at 12:05 PM
What Are Analysts Expecting From Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Over The Next Few Years?What Are Analysts Expecting From Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Over The Next Few Years?
finance.yahoo.com - May 2 at 12:05 PM
Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming MilestonesSyros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
finance.yahoo.com - May 1 at 11:38 AM
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue EstimatesSyros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 1 at 11:38 AM
Syros to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019Syros to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019
finance.yahoo.com - April 24 at 11:53 AM
NetworkNewsBreaks - Syros Pharmaceuticals SYRS Realizes Proceeds of Approximately $70M Through Concurrent Public OfferingsNetworkNewsBreaks - Syros Pharmaceuticals SYRS Realizes Proceeds of Approximately $70M Through Concurrent Public Offerings
www.marketwatch.com - April 23 at 3:51 PM
Syros to Host Key Opinion Leader Symposium on CDK7 Inhibition on April 24, 2019Syros to Host Key Opinion Leader Symposium on CDK7 Inhibition on April 24, 2019
finance.yahoo.com - April 18 at 12:25 PM
3 Small Biotech Stocks With Insider Buying3 Small Biotech Stocks With Insider Buying
seekingalpha.com - April 17 at 3:57 PM
Friday 4/12 Insider Buying Report: SYRS, HYFriday 4/12 Insider Buying Report: SYRS, HY
www.marketwatch.com - April 12 at 1:54 PM
Syros Pharmaceuticals Platform Undervalued After DipSyros Pharmaceuticals Platform Undervalued After Dip
seekingalpha.com - April 11 at 8:25 AM
Syros closes $70M equity offeringsSyros closes $70M equity offerings
seekingalpha.com - April 9 at 8:58 PM
Syros Announces Closing of Concurrent Public OfferingsSyros Announces Closing of Concurrent Public Offerings
finance.yahoo.com - April 9 at 8:58 PM
Heres Why Syros Pharmaceuticals Is Collapsing TodayHere's Why Syros Pharmaceuticals Is Collapsing Today
www.fool.com - April 6 at 10:54 AM
Here's Why Syros Pharmaceuticals Is Collapsing TodayHere's Why Syros Pharmaceuticals Is Collapsing Today
finance.yahoo.com - April 5 at 3:42 PM
Syros down 25% on pricing equity offeringsSyros down 25% on pricing equity offerings
seekingalpha.com - April 5 at 11:16 AM
Syros Announces Pricing of $70 Million Concurrent Public OfferingsSyros Announces Pricing of $70 Million Concurrent Public Offerings
finance.yahoo.com - April 5 at 11:16 AM
The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine PartnershipThe Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership
finance.yahoo.com - April 5 at 11:16 AM
Syros down 8% after hours on equity offeringsSyros down 8% after hours on equity offerings
seekingalpha.com - April 4 at 8:51 PM
Syros Announces Proposed Concurrent Public Offerings of Common Stock with Warrants to Purchase Common Stock and Preferred Stock with Warrants to Purchase Common StockSyros Announces Proposed Concurrent Public Offerings of Common Stock with Warrants to Purchase Common Stock and Preferred Stock with Warrants to Purchase Common Stock
finance.yahoo.com - April 4 at 8:51 PM
Syros Presents New Preclinical Data on SY-1365 and SY-5609 at AACR Annual MeetingSyros Presents New Preclinical Data on SY-1365 and SY-5609 at AACR Annual Meeting
finance.yahoo.com - April 2 at 7:43 PM
Syros Pharmaceuticals (SYRS) Investor Presentation - Slideshow - Seeking AlphaSyros Pharmaceuticals (SYRS) Investor Presentation - Slideshow - Seeking Alpha
seekingalpha.com - March 15 at 12:26 PM
Did You Manage To Avoid Syros Pharmaceuticals’s (NASDAQ:SYRS) 47% Share Price Drop?Did You Manage To Avoid Syros Pharmaceuticals’s (NASDAQ:SYRS) 47% Share Price Drop?
finance.yahoo.com - March 12 at 8:53 PM
Syros Pharmaceuticals (SYRS) CEO Dr. Nancy Simonian on Q4 2018 Results - Earnings Call TranscriptSyros Pharmaceuticals (SYRS) CEO Dr. Nancy Simonian on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 8 at 3:55 PM
Edited Transcript of SYRS earnings conference call or presentation 7-Mar-19 1:30pm GMTEdited Transcript of SYRS earnings conference call or presentation 7-Mar-19 1:30pm GMT
finance.yahoo.com - March 8 at 12:14 PM
Form S-8 Syros Pharmaceuticals, - StreetInsider.comForm S-8 Syros Pharmaceuticals, - StreetInsider.com
www.streetinsider.com - March 7 at 3:45 PM
Syros Pharmaceuticals, Inc. (SYRS) Q4 2018 Earnings Conference Call TranscriptSyros Pharmaceuticals, Inc. (SYRS) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 7 at 3:45 PM
Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class ProgramsSyros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs
finance.yahoo.com - March 7 at 12:37 PM
Syros to Participate in Upcoming Investor Conferences in MarchSyros to Participate in Upcoming Investor Conferences in March
finance.yahoo.com - March 6 at 11:49 AM
Syros to Present New Preclinical Data on Its Selective CDK7 Inhibitors, SY-1365 and SY-5609, at AACR Annual MeetingSyros to Present New Preclinical Data on Its Selective CDK7 Inhibitors, SY-1365 and SY-5609, at AACR Annual Meeting
finance.yahoo.com - February 28 at 12:43 PM
Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019
finance.yahoo.com - February 28 at 12:43 PM
Syros Pharmaceuticals Inc.Syros Pharmaceuticals Inc.
www.barrons.com - January 23 at 3:45 PM
Syros Pharmaceuticals (SYRS) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowSyros Pharmaceuticals (SYRS) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 10 at 3:51 PM
Syros Announces Strategic Priorities and Expected MilestonesSyros Announces Strategic Priorities and Expected Milestones
finance.yahoo.com - January 7 at 10:45 AM
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel